Organon International

Jump to: navigation, search

Organon is a pharmaceutical company headquartered in Roseland, New Jersey that is part of Akzo Nobel.

Organon deals in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, HRT and anesthesia. Organon sells to international markets.

Organon was founded by Dr.Saal van Zwanenberg in Oss, the Netherlands, in 1923 as Zwanenberg-Organon. Its first product was insulin. In the thirties it manufactured estrogens. The production of cortison was initiated in 1953. The now named Koninklijke Zwanenberg-Organon (KZO) fused with the fiber producer AKU in 1969 to become AKZO, later Akzo Nobel. Organon is the human health care business unit of Akzo Nobel and transferred its headquarters to the USA while the main headquarter of Akzo Nobel remains in Arnhem. Manufacturing facilities are in the Netherlands, Germany, the United Kingdom, China, Japan, and the USA.

Products include: Remeron, Remeron SolTab, Sustanon, Deca-Durabolin, Pregnyl and a variety of other contraceptive products.

As of March 12, 2007, Organon BioSciences N.V. has been acquired by Schering Plough [1].

References

1. "Schering-Plough to Acquire Organon BioSciences,"

External links

Template:Med-company-stub

de:Organon (Pharma) nl:Organon (multinational)



Linked-in.jpg